Director, Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California
Dana Goldman is a Professor and the Leonard D. Schaeffer Chair and Director of the USC Schaeffer Center for Health Policy and Economics. In 2016, he was appointed a Distinguished Professor of the University of Southern California. Until Fall 2009, he held RAND’s Distinguished Chair in Health Economics and directed RAND’s program in Economics, Finance, and Organization. He is also an Adjunct Professor of Health Services and Radiology at UCLA.
Dr. Goldman is a nationally-recognized health economist influential in both academic and policy circles. He is the author of over 100 articles and book chapters, including articles in some of the most prestigious medical, economic, health policy, and statistics journals. He is a health policy advisor to the Congressional Budget Office, and is a frequent speaker on health care issues. He serves on several editorial boards including Health Affairs and the American Journal of Managed Care. He is also a founding editor of the Forum for Health Economics and Policy, an online journal devoted to health economics and health policy.
Dr. Goldman’s work has been featured in the New York Times, Wall Street Journal, Washington Post, Business Week, U.S. News and World Report, The Economist, NBC Nightly News, CNN, National Public Radio, and other media. Dr. Goldman was the 2009 recipient of the Eugene Garfield Economic Impact Prize, recognizing outstanding research demonstrating how medical research impacts the economy. He was awarded the National Institute for Health Care Management Research Foundation award for excellence in health policy, and the Alice S. Hersh New Investigator Award recognizing the contributions of a young scholar to the field of health services research. He also has served on several panels for the National Academy of Sciences and Institute of Medicine, including a current panel on the fiscal future of the United States.
Dr. Goldman’s research sponsors include the National Institutes of Health, National Institute on Aging, National Cancer Institute, National Science Foundation, Amgen, Merck, Genentech, Pfizer, UnitedHealth, Pacificare, California Healthcare Foundation, Smith Richardson Foundation, Department of Defense, Department of Labor, and the Agency for Healthcare Research and Quality.
Dr. Goldman is also a research associate with the National Bureau of Economic Research, the nation’s leading economic research organization. He is the director of the RAND/UCLA Health Services Research Postdoctoral Training Program. He is also a founder and managing director of Precision Health Economics, a consulting firm to the health care industry. Dr. Goldman received his B.A. summa cum laude from Cornell University and a Ph.D. in Economics from Stanford University.
Obesity, second to smoking as the most preventable cause of US deaths, needs new approaches
Jan 28, 2020 08:38 am UTC| Insights & Views Health
The opioid crisis and deaths related to e-cigarette use among teenagers have dominated news headlines recently. Recently, the Centers for Disease Control and Prevention reported that 34 people had died as a result of...
Why your employer-sponsored insurance may ultimately not be good for you
Sep 10, 2019 20:30 pm UTC| Insights & Views Business
The Democratic presidential debates, which resume Sept. 12, have highlighted a deep disagreement over the future American health care system. Reflecting the anger of voters over medical costs, Sens. Bernie Sanders,...
Why academics consulting with industry on health care may be an idea whose time has come
Dec 21, 2016 14:28 pm UTC| Insights & Views Business Economy
Perhaps ironically, the advent of the Trump presidency could signal an even greater role for academics in shaping public policy. The president-elect has set out an ambitious agenda, but with many details left to fill in,...
Putin’s Russia: first arrests under new anti-LGBT laws mark new era of repression
Canada needs a national strategy for homeless refugee claimants